Reuters logo
BRIEF-Pernix Therapeutics receives favorable opinion in litigation with Actavis Laboratories
February 23, 2017 / 1:22 PM / 8 months ago

BRIEF-Pernix Therapeutics receives favorable opinion in litigation with Actavis Laboratories

Feb 23 (Reuters) - Pernix Therapeutics Holdings Inc:

* Pernix Therapeutics Holdings - received favorable opinion in litigation with actavis laboratories regarding proposed generic version of zohydro er

* Pernix Therapeutics-judge entered order enjoining actavis from engaging in commercial manufacture, use, offer to sell, or sale in u.s. For zohydro er

* Pernix Therapeutics-judge also entered order enjoining actavis from importation into united states of actavis’ anda product before expiration of 2 patents Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below